252 related articles for article (PubMed ID: 31372978)
1. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R
Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.
Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P;
BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076
[TBL] [Abstract][Full Text] [Related]
3. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
Holme PA; Brosstad F; Tjønnfjord GE
Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
[TBL] [Abstract][Full Text] [Related]
4. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P
Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
[TBL] [Abstract][Full Text] [Related]
5. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry.
Borg JY; Guillet B; Le Cam-Duchez V; Goudemand J; Lévesque H;
Haemophilia; 2013 Jul; 19(4):564-70. PubMed ID: 23574453
[TBL] [Abstract][Full Text] [Related]
6. Patients with haemophilia A with inhibitors in China: a national real-world analysis and follow-up.
Dou X; Liu W; Poon MC; Zhang X; Wu J; Zeng X; Wu R; Hu Q; Li C; Wang X; Song X; Chen L; Zhang L; Xue F; Yang R
Br J Haematol; 2021 Mar; 192(5):900-908. PubMed ID: 33534930
[TBL] [Abstract][Full Text] [Related]
7. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study.
Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ
Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536
[TBL] [Abstract][Full Text] [Related]
8. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
Knoebl P; Marco P; Baudo F; Collins P; Huth-Kühne A; Nemes L; Pellegrini F; Tengborn L; Lévesque H;
J Thromb Haemost; 2012 Apr; 10(4):622-31. PubMed ID: 22321904
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A;
Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903
[TBL] [Abstract][Full Text] [Related]
10. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.
Baudo F; Collins P; Huth-Kühne A; Lévesque H; Marco P; Nemes L; Pellegrini F; Tengborn L; Knoebl P;
Blood; 2012 Jul; 120(1):39-46. PubMed ID: 22618709
[TBL] [Abstract][Full Text] [Related]
11. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China.
Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W
Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689
[No Abstract] [Full Text] [Related]
13. Acquired haemophilia syndrome: pathophysiology and therapy.
Elezović I
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
[TBL] [Abstract][Full Text] [Related]
15. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
Škunca Ž; Peraica AP
Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630
[TBL] [Abstract][Full Text] [Related]
17. Management of acquired haemophilia A in severe Covid-19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis.
Gelbenegger G; Traby L; Rahimi N; Knöbl P
Br J Clin Pharmacol; 2023 Feb; 89(2):908-913. PubMed ID: 36369653
[TBL] [Abstract][Full Text] [Related]
18. Relapse pattern and long-term outcomes in subjects with acquired haemophilia A.
Mizrahi T; Doyon K; Dubé E; Bonnefoy A; Warner M; Cloutier S; Demers C; Castilloux JF; Rivard GE; St-Louis J
Haemophilia; 2019 Mar; 25(2):252-257. PubMed ID: 30694571
[TBL] [Abstract][Full Text] [Related]
19. FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry.
Borg JY; Négrier C; Durieu I; Dolimier E; Masquelier AM; Lévesque H;
Haemophilia; 2015 May; 21(3):330-337. PubMed ID: 25359571
[TBL] [Abstract][Full Text] [Related]
20. Acquired haemophilia: an overview for clinical practice.
Kessler CM; Knöbl P
Eur J Haematol; 2015 Dec; 95 Suppl 81():36-44. PubMed ID: 26679396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
